NTRC is a precision medicine company dedicated to the development of new anti-cancer drugs. NTRC facilitates the development of novel therapies by providing immunotherapy assay development & screening; cancer cell line profiling; pharmacogenomics analysis; combination studies; and target residence time measurements for protein kinases. Assay read-outs for the cancer immunotherapy drug targets Arginase 1; IDO1; and TDO are supplied to clients globally. NTRC has internal drug discovery programs on TTK, IDO1 and TDO. For more information please visit www.ntrc.nl or contact info@ntrc.nl
NTRC is a precision medicine company dedicated to the development of new anti-cancer drugs. NTRC facilitates the development of novel therapies by providing immunotherapy assay development & screening; cancer cell line profiling; pharmacogenomics analysis; combination studies; and target residence time measurements for protein kinases. Assay read-outs for the cancer immunotherapy drug targets Arginase 1; IDO1; and TDO are supplied to clients globally. NTRC has internal drug discovery programs on TTK, IDO1 and TDO. For more information please visit www.ntrc.nl or contact info@ntrc.nl
Company Information
- Industry
- Research
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Kloosterstraat 9 (visiting address) Noord-Brabant Oss
- City
- Oss
- Region
- Noord-Brabant
- Postal Code
- 5349 AB
- Country
- Netherlands
